QoL Improvement With Infliximab Maintenance Therapy in CD*

Feagan BG et al. Gastroenterology. 2002;122:A615. Abstract W1351.

Single infusion

Infliximab 5 mg/kg
maintenance

3

1

0.2

p=0.015

p=0.014

p<0.072

p<0.001

p=0.001

p<0.023

0

5

10

15

20

25

30

IBDQ

Physical

Component

Summary

Mental

Component

Summary

Median Change From
Baseline to Week 54

Infliximab 10 mg/kg
maintenance

21

28

4.4

5

2.8

4.6

*Preliminary data